Paclitaxel, Carboplatin, and Bevacizumab With or Without Cixutumumab in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer

Clinical trial NCT00955305 · TERMINATED

Trial details

NCT number: NCT00955305
Sponsor: National Cancer Institute (NCI)
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Large Cell Lung Carcinoma Lung Adenocarcinoma Recurrent Non-Small Cell Lung Carcinoma Stage IV Non-Small Cell Lung Cancer Bronchioloalveolar Lung Carcinoma

Start date: 2010-03-01
Primary completion: 2016-01-01
Enrollment: 175

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.